PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland (RCSI), Dublin, Ireland.\', \'Department of Anaesthesia and Critical Care, RCSI, Dublin, Ireland.\', \'Department of Infectious Diseases, Beaumont Hospital, Dublin, Ireland.\', \'Department of Haematology, Beaumont Hospital, Dublin, Ireland.\', \'Department of Tropical Medicine and International Health, RCSI, Dublin, Ireland.\', \'St James\'s Hospital, Trinity College Dublin, Dublin, Ireland.\', \'Centre for Experimental Pathogen Host Research, University College Dublin, Dublin, Ireland.\', \'St Vincent\'s University Hospital, Dublin, Ireland.\', \'National Coagulation Centre, St James\'s Hospital, Dublin, Ireland.\', \'National Children\'s Research Centre, Our Lady\'s Children\'s Hospital Crumlin, Dublin, Ireland.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/bjh.17273
?:doi
?:hasPublicationType
?:journal
  • British journal of haematology
is ?:pmid of
?:pmid
?:pmid
  • 33326604
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.036
?:rankingScore_hIndex
  • 169
is ?:relation_isRelatedTo_publication of
?:title
  • Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activation.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all